Wani zaman kwamitin kwanan nan a Majalisar Tarayyar Turai ya haifar da sautin sauti masu ban mamaki da yawa waɗanda suka yadu a kan Twitter kuma waɗanda suka mai da hankali sosai, musamman, game da laifuffukan da ake zargin fitaccen mai kera allurar C-19 na duniya, Pfizer.
Membobin kwamitin sun kasance suna fatan yin "tambayoyi marasa dadi" - kamar yadda memba na kwamitin Faransa Virginie Joron ta saka wani bidiyo da aka yi tweeted - zuwa Shugaban Kamfanin Pfizer Albert Bourla, amma, bayan sokewar Bourla, dole ne ya daidaita maimakon marassa galihu kuma har yanzu wakilin kamfanin Janine Small.
Amma babbar matsalar ita ce, idan mambobin kwamitin suka yi tambayoyi marasa dadi kwata-kwata, suna tambayarsu na kamfanin da ba daidai ba ne gaba daya, sannan kuma, cewa ta yin hakan, suna rufa wa wasu tambayoyi marasa dadi: sama da duka, ga EU kanta.
Manyan kwangilolin sayen kayayyaki da hukumar Tarayyar Turai karkashin jagorancin shugabar hukumar Ursula von der Leyen, ta sanya wa hannu a madadin dukkan kasashen kungiyar EU, su ne tushen damuwar komitin, da kuma zargin cin hanci da rashawa da ya dabaibaye shari'ar, sakamakon sakonnin tes da ya kamata shugaban hukumar na Jamus ya yi musanyarsa da Bourla da ba ya nan.
Tambayar sa'ar ita ce: Ina Bourla? A cikin wani aiki na haɗin gwiwa, membobin kwamitin masu mahimmancin rigakafi kamar Joron har ma sun nuna alamun da ke karanta "Ina Pfizer-CEO/Transparency?" yayin zaman.
Wakiliyar Faransa a Majalisar Tarayyar Turai Virginie Joron a taron kwamitin COVI na ranar 10 ga Oktoba
Amma tambayar da ta fi dacewa ita ce: Ina BioNTech? Domin, ko da yake mutum ba zai sami ra'ayin sauraron mambobin kwamitin ba, waɗannan kwangilolin ba, ba tare da Pfizer ba ne, amma tare da haɗin gwiwar Pfizer. da kuma Kamfanin na Jamus BioNTech kuma, ƙari ga haka, shi ne kamfanin Jamus BioNTech, ba Pfizer, shine mai riƙe izinin tallace-tallace a cikin EU, kamar yadda yake akan kusan duk kasuwannin da abin yake a zahiri. BioNTech's, ba na Pfizer ba, ana siyar da maganin.
Cikakkun bayanai daga Hukumar Kula da Magunguna ta Turai shafin bayani akan allurar "Comirnaty".
Bugu da ƙari, BioNTech ba kawai wani kamfani ne na Jamus ba. Kamfanin Jamus ne wanda, kamar yadda aka tattauna dalla-dalla a labarina na Brownstone na farko nan, gwamnatin Jamus ta samu ci gaba sosai tare da ba da tallafi a tsawon tarihinta. Tabbas, gwamnatin Jamus ta dauki nauyin sosai kafa na BioNTech a matsayin wani ɓangare na shirin “Go-Bio” na musamman da aka sadaukar don haɓaka farawar fasahar kere-kere ta Jamus, wanda ya ba da kuɗi ba kawai ba, har ma da jagoranci na gwamnati, da kuma taimako wajen jawo hannun jari masu zaman kansu. (Duba bayanin shirin [a cikin Jamusanci] nan.)
Shugabar Hukumar Tarayyar Turai ta Jamus, Ursula von der Leyen, ita kanta mamba ce a cikin gwamnatocin Jamus guda biyu da suka ci gaba da ba da tallafi na "Go-Bio", a zagaye biyu, na farko ga ƙungiyar binciken Babban Jami'in BioNTech Ugur Sahin a Jami'ar Mainz, wanda ya fara a 2007, sa'an nan kuma ga kamfanin bayan kafa shi a 2008. (See). nan [a cikin Jamusanci].) Lallai Von der Leyen ta kasance memba a gwamnatin Jamus a mukamai daban-daban na tsawon shekaru goma sha hudu, a baya-bayan nan a matsayin ministar tsaro, kafin daga bisani a mika ta kai tsaye zuwa matsayin shugabar hukumar Tarayyar Turai – duk da cewa ba ta taba zama ‘yar takara ba!
Sama da shekaru goma, duk da ci gaba da goyon bayan gwamnatin Jamus, BioNTech ya kasance, a zahiri, farawa na dindindin, wanda kawai ya taɓa yin asara kuma bai taɓa kusan kawowa kasuwa ba. Har sai, wato, zuwan Covid-19, lokacin da kamfanin ya hanzarta mayar da hankali ga aikinsa na haɓaka maganin ciwon daji na mRNA (wanda, abin mamaki, shi ma ake kira "alurar rigakafi") don haɓaka rigakafin mRNA na Covid-19.
Ba abin mamaki ba, mai daukar nauyin kamfanin na kasar Jamus, shi ma zai zama babban mai daukar nauyin rigakafinsa, inda ya ba wa kamfanin tallafin Yuro miliyan 375 don tallafawa kokarinsa a watan Satumba na 2020. A ranar 17 ga Satumba, kwanaki biyu kacal bayan sanarwar bayar da tallafin. BioNTech ya sanar cewa zai sayi babban wurin samar da kayayyaki a Marburg wanda zai ba shi damar zama - kusan dare ɗaya - babban mai kera alluran rigakafi a kansa kuma ba wai kawai ya dogara da masu lasisi kamar Pfizer don kera a madadin sa ba.
(Kayan aikin da aka siya, ba zato ba tsammani, ɗan rashin mutunci ne Behringwerke, wanda, a matsayinsa na wani reshen IG Farben da ya fi ƙaƙƙarfan amincewar sinadarai, ya shiga cikin gwajin rigakafin gwaji kan fursunonin sansani a Buchenwald a lokacin yakin duniya na biyu. Duba shigarwar farko nan, misali, daga Buchenwald Memorial Museum. Amma lura cewa da yawa sun mutu fiye da fursunoni biyar da aka ambata.)
Amma ba gwamnatin Jamus ce kawai ta tallafa wa rigakafin BioNTech ba, haka ma EU da kanta! Tabbas, a cikin watan Yunin 2020, tun ma kafin Jamus ta shiga da tallafin Yuro miliyan 375, bankin zuba jari na Tarayyar Turai na EU (EIB) - karkashin jagorancin tsohon shugabanta, tsohon jami'in ofishin harkokin waje na Jamus Werner Hoyer - ya riga ya ba wa kamfanin. Yuro miliyan 100 na tallafin bashi don tallafawa kokarinta na rigakafin C-19.
Wannan shi ne irin wannan daraja ta biyu da EIB ta ƙara zuwa BioNTech. A tsakiyar Disamba 2019 - i, kusan lokaci guda tare da rahoton bullar Covid-19 na farko a Wuhan, China! – EIB ya riga ya samar da kamfanin Yuro miliyan 50 na tallafin bashi.
Yana da daidai waɗannan haɗin kai, ba a ce dangantakar da ke tsakanin BioNTech, gwamnatin Jamus da EU da kanta da aka boye ta da yawa jama'a, amma gaba daya m, "abin kunya" game da saƙonnin rubutu tsakanin von der Leyen da Bourla. Batun kawo sakonnin tes a fili yana nuna cin hanci da rashawa.
Amma matsalar ba cin hanci da rashawa ba ce. Yana da ma'ana rikici na ban sha'awa wanda aka gina shi a cikin izinin EU da tsarin sayayya tun daga farko, amma hakan ya kasance marar ganuwa muddin aka yi watsi da BioNTech. Wannan shi ne mai yiwuwa dalilin da ya sa kamfanin ya kasance persona non grata a sauraron kwamitin majalisar EU kan Covid: wanda aka fi sani da Kwamitin COVI (sic).
Wadanda kawai suka sani game da sauraron karar daga Twitter ba shakka za su yi mamakin sanin cewa ya shafi ba kanana kawai ba amma wakilai daga kamfanonin da ba su gaza biyar ba kuma wannan shi ne karo na biyu na irin wannan zama guda biyu, na farko da ya kunshi wakilai daga wasu kamfanoni hudu. (Cikakken bidiyo yana nan nan da kuma nan.)
Wadanda aka gayyata sun hada da wakilai daga Moderna (Shugaba Stéphane Bancel), daga kamfanin Anglo-Swedish AstraZeneca, wanda ba a yi amfani da rigakafin Covid-19 ba a cikin EU sama da shekara guda, har ma daga CureVac, mai haɓaka sauran ɗan takarar rigakafin mRNA na Jamus, wanda bai taɓa samun izini ba tun farko! Amma, abin mamaki, babu kasancewar BioNTech: kawai mai shi da mai ba da izinin tallace-tallace don abin da ya kasance mafi yawan amfani da maganin C-19 a cikin Tarayyar Turai.
Maimakon haka, mambobin kwamitin sun biya a masu zaman kansu Ziyarci hedkwatar BioNTech a Mainz, wanda ya haɗa da, kowane shirin da ake da shi nan, "Budaddiyar tattaunawa tsakanin masana BioNTech da masana kimiyya da aikin COVI, da abincin rana: abincin abincin yatsa da abubuwan sha." Sauti da gaske yana fuskantar juna!
Amma ba wai BioNTech kawai ba ya halarta a taron jama'a, har ma da kalmar "BioNTech" kawai a cikin jama'a ya zama abin ƙyama ga mambobin kwamitin.
Don haka, yayin buɗe taron na baya-bayan nan, shugabar kwamitin Kathleen Van Brempt a hankali ta caccaki ƙaramin kocin Albert Bourla don bai nuna ba, tare da lura cewa shi "mutum ne mai mahimmanci ga kwamitin" kuma kamfanin shine, bayan haka, "mafi girma mai samarwa kuma mai samar da alluran rigakafin Covid-19 a cikin Tarayyar Turai" - ba tare da ambaton BioNTech ba, kamar dai babu wani kamfani kuma babu wani kamfani!
Wannan duk da cewa bayanin kan siyan Covid-19 akan gidan yanar gizon hukumar EU ya bayyana a sarari cewa odar gargantuan na EU na alluran rigakafi biliyan 2.4 an sanya shi tare da Pfizer. da kuma BioNTech, kuma har ma da gaske - kamar yadda ya kamata - yana ba BioNTech babban lissafin kuɗi. Don haka, me ya sa Shugaban Kamfanin BioNTech Ugur Sahin ba mutum ne mai sha'awar kwamitin ba?
Bayani kan EU “Polio Vaccine Portfolio” daga gidan yanar gizon Hukumar Tarayyar Turai
Daga baya, dan majalisar Holland Rob Roos zai haskaka Bourla da ba ya nan saboda rashin sha'awar yin shaida a gaban kwamitin, amma da gaske yana sha'awar "biliyoyin riba tare da kuɗin haraji na 'yan EU."
Shin Rob Roos bai san cewa Pfizer ya raba ribar sa 50-50 tare da BioNTech kuma gabaɗayan BioNTech ya sami riba mai yawa akan tallace-tallacen rigakafin Covid-19 fiye da abokin tarayya na Amurka? (Dubi labarina na Brownstone na farko nan.) Shin ya yi irin wannan lura ga wakilan BioNTech a kan "abincin yatsa" a Mainz?
Bugu da ƙari, shin gaskiyar cewa BioNTech tana biyan kusan kashi ɗaya bisa uku na ribar da take samu a harajin kamfanoni, don haka bai wa gwamnatin Jamus kanta sha'awa kai tsaye ga nasarar da kamfanin ya samu, ya haifar da wasu muhimman batutuwa game da amincin tsarin sayan fiye da yadda von der Leyen da Bourla suka yi musayar rubutu?
Wannan ba zai ce komai ba game da fa'idar fa'idar haɓakar Jamusanci na kamfani wanda ya tashi daga kusan babu kudaden shiga zuwa Yuro biliyan 19 na kudaden shiga a cikin shekara guda! Sama da Yuro biliyan 15 na waɗannan kudaden shiga sun wakilci riba, wanda ke baiwa kamfanin kusan ribar kashi 80%. Kuma Rob Roos da abokan aikinsa suna son magana ne kawai Pfizer na riba?
'Yar majalisar Faransa Michèle Rivasi za ta ci gaba da makircin shiru na ban mamaki lokacin da aka tayar da muhimmin batu na rashin zaman lafiya na mRNA: watau, a sauƙaƙe, gaskiyar cewa wani ɓangare na mRNA a cikin maganin ya lalace kuma don haka a zahiri baya aiki don samar da antigen da aka yi niyya (protein furotin).
Kamar yadda Rivasi ya ambata, Hukumar Kula da Magunguna ta Turai (EMA) ta tayar da wannan batu a matsayin abin damuwa. Amma daftarin EMA mai dacewa yana buƙatar batun da za a magance shi azaman "SO" - takamaiman wajibi - ta "MAH." Kuma menene "MAH?" Da kyau, shine mai riƙe izinin talla, ba shakka, kuma mai ikon tallan shine BioNTech. Me yasa a cikin duniya Rivasi ya tayar da batun tare da Pfizer ba tare da BioNTech ba, kamar yadda dokokin EU ke buƙata?!
An karbo daga shafi na 140 na Rahoton Ƙimar EMA ku Comirnaty
Amma watakila mafi girman misali na tsoron ’yan majalisa na furta kalmar “BioNTech” dan majalisar Romania ne Cristian Terhes ya bayar. Terhes ya zargi Pfizer da fara gwajin rigakafin "Covid-19" a ranar 14 ga Janairu, 2020, kwanaki kadan bayan da gwamnatin kasar Sin ta buga jerin kwayoyin cutar. Ya sake maimaita zargin a baya. taron manema labarai na taya murna.
Wataƙila tabbas an fara gwaji da sauri. Wataƙila ya yi, tunda BioNTech bai taɓa yin sirrin gaskiyar cewa ya fara haɓakawa ba da rigakafin a tsakiyar watan Janairu 2020, daidai bayan da aka buga jerin kwayoyin halitta. Duba, alal misali, tsarin lokaci na BioNTech “Project Lightspeed”. nan. Amma Pfizer bai shiga aikin ba sai bayan watanni biyu, lokacin da ta sanya hannu kan yarjejeniyar haɗin gwiwa da BioNTech.
Don haka, Cristian Terhes yana nan a zahiri yana nufin BioNTech da kiran shi "Pfizer!" Me yasa? Me yasa aka boye sunan wanda ke da alhakin gwajin, wanda dole ne a nuna shi a fili a cikin takardar EMA da Terhes ya ambata?
Ko da lokacin da aka fi yawan jama'a a cikin sauraron shine, a zahiri, motsa jiki ne kawai: wato, sanannen lokacin "gotcha" lokacin da Rob Roos da alama ya sami ƙaramin gwagwarmayar ƙarami don "yarda" cewa Pfizer bai taɓa gwada ko maganin ya hana yaduwar cutar ba. Rob Roos tabbas yayi gaskiya, kamar yadda ya lura a ciki a tweet, cewa wannan yana lalata duk dalilan fasfo na rigakafi: "a yi wa wasu alluran rigakafi" hakika ƙarya ce.
Amma duk da haka an sake maimaita wannan ƙaryar - sama da duka, gwamnatoci da ƙungiyoyin gwamnatoci kamar Tarayyar Turai - gaskiyar cewa ba a tsara gwajin asibiti don gwada rigakafin kamuwa da cuta ba tun daga farko. Babu kasa da iko fiye da Tal Zaks, sannan Babban Jami'in Lafiya na Moderna, ya yarda da hakan a bainar jama'a Oktoba 2020 – a lokacin da ake ci gaba da gwaji! (Duba sharhin Zaks ga Peter Doshi a cikin British Medical Journal nan.)
Kuma kamar yadda ya shafi gwajin da ake kira "Pfizer", ta hanyar, BioNTech shine mai daukar nauyin gwaji, kuma an gano BioNTech a cikin rikodin gwajin asibiti a matsayin "jam'iyyar da ke da alhakin" don bayanin da ya shafi shi. An jera Pfizer kawai a matsayin "mai haɗin gwiwa."
Daga allurar BioNTech/Pfizer C-19 rikodin gwaji na asibiti
Anan akwai sunayen wasu fitattun mambobi na rigakafin rigakafi masu mahimmanci ko masu shakka na Majalisar EU: Virginie Joron (Faransa), Cristian Terhes (Romania), Ivan Sinčić (Croatia), Rob Roos (Netherland), Michèle Rivasi (Faransa) da Christine Anderson (Jamus). Yaushe ɗayansu zai shawo kan tambarin su kuma ya fara magana game da BioNTech?
Idan sun taɓa yin hakan, za su so su yi waɗannan tambayoyin da ba su da daɗi: Shin bai kamata Ursula von der Leyen ta daina yin shawarwari da wani kamfani da gwamnatin da ita kanta memba ce ta ci gaba da ɗaukaka ƙasa da shekara ɗaya ba?
Kuma yaya game da Jamus kanta, wacce ta shiga cikin tattaunawar kai tsaye tare da mai kula da masana'antu a matsayin memba na "Tawagar Haɗin gwiwar Tattaunawa" na ƙasa bakwai waɗanda suka taimaka wa Hukumar?
-
Robert Kogon shi ne sunan alkalami na wani ɗan jarida da ake bugawa da yawa wanda ke yin rubuce-rubuce kan al'amuran Turai.
Duba dukkan posts
